A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A

Clinical trial NCT01724814 · COMPLETED

Trial details

NCT number: NCT01724814
Sponsor: Hanmi Pharmaceutical Company Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus

Start date: 2012-12-20
Primary completion: 2014-07-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.